These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The A17 enhancer directs expression of Myf5 to muscle satellite cells but Mrf4 to myonuclei. Chang TH, Vincent SD, Buckingham ME, Zammit PS. Dev Dyn; 2007 Dec; 236(12):3419-26. PubMed ID: 17948300 [Abstract] [Full Text] [Related]
6. Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis. Zammit PS. Semin Cell Dev Biol; 2017 Dec 23; 72():19-32. PubMed ID: 29127046 [Abstract] [Full Text] [Related]
8. MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions. Ishibashi J, Perry RL, Asakura A, Rudnicki MA. J Cell Biol; 2005 Nov 07; 171(3):471-82. PubMed ID: 16275751 [Abstract] [Full Text] [Related]
19. Effect of phase limited inhibition of MyoD expression on the terminal differentiation of bovine myoblasts: no alteration of Myf5 or myogenin expression. Muroya S, Nakajima I, Oe M, Chikuni K. Dev Growth Differ; 2005 Sep 15; 47(7):483-92. PubMed ID: 16179075 [Abstract] [Full Text] [Related]
20. Loss of MyoD and Myf5 in Skeletal Muscle Stem Cells Results in Altered Myogenic Programming and Failed Regeneration. Yamamoto M, Legendre NP, Biswas AA, Lawton A, Yamamoto S, Tajbakhsh S, Kardon G, Goldhamer DJ. Stem Cell Reports; 2018 Mar 13; 10(3):956-969. PubMed ID: 29478898 [Abstract] [Full Text] [Related] Page: [Next] [New Search]